Leering Partners Lifts Disc Medicine, Inc. (IRON) Following EPP Drug NDA Application
Disc Medicine Inc. (NASDAQ:IRON) is one of the best biotech stocks to buy according to Wall Street analysts.
Disc Medicine Inc. (IRON)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 0 | $0 | 0% | |
| 2. | OrbiMed Advisors Samuel Isaly | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | ||
| 4. | 0 | $0 | 0% | ||
| 5. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $36.00 | 222,223 | $8,000,028.00 | 420,549 | 2024-06-17 | Filing | |
| $36.00 | 10,986 | $395,496.00 | 235,391 | 2024-06-17 | Filing | |
| $36.00 | 43,944 | $1,581,984.00 | 941,569 | 2024-06-17 | Filing | |
| $36.00 | 28,404 | $1,022,544.00 | 608,611 | 2024-06-17 | Filing | |
| $36.00 | 10,986 | $395,496.00 | 235,391 | 2024-06-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $70.11 | 27,136 | $1,902,504.96 | 0 | 2026-09-11 | Filing | |
| $79.96 | 18 | $1,439.28 | 13,427 | 2026-09-04 | Filing | |
| $79.96 | 759 | $60,689.64 | 312,230 | 2026-09-04 | Filing | |
| $79.96 | 912 | $72,923.52 | 318,866 | 2026-09-04 | Filing | |
| $79.98 | 54 | $4,318.92 | 13,445 | 2026-09-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
15 Best Biotech Stocks to Buy According to Wall Street Analysts
In this article, we will examine the 15 Best Biotech Stocks to Buy According to Wall Street Analysts.
This is Why Disc Medicine, Inc. (IRON) is a Buy on Wall Street
Disc Medicine, Inc. (NASDAQ:IRON) is one of the best 52-week high stocks to buy right now. On November 20, analysts at Jefferies reiterated a Buy rating on the stock with a $127 price target.
12 Best 52-Week High Stocks to Buy Right Now
In this article, we take a look at the 12 Best 52-Week High Stocks to Buy Right Now.
Disc Medicine, Inc. (IRON) Set to Submit NDA for Bitopertin in October 2025
We recently compiled a list of 10 Best Mid Cap Stocks to Buy According to Billionaires. Disc Medicine, Inc. stands sixth on our list and nears FDA filing for the first-ever EPP treatment.
10 Best Mid Cap Stocks to Buy According to Billionaires
In this article, we will be taking a look at the 10 best mid-cap stocks to buy according to billionaires.
Morgan Stanley Assumes Coverage of Disc Medicine (IRON) With $85 PT
Disc Medicine, Inc. (NASDAQ:IRON) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.
11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds
In this article, we will discuss the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.
Leerink Partners Reiterates a Buy Rating on Disc Medicine (IRON) With an $85 Price Target
Disc Medicine, Inc. (NASDAQ:IRON) is one of the 13 Small Cap Stocks Analysts Are Bullish On.
13 Small Cap Stocks Analysts Are Bullish On
In this article, we will look at the 13 Small Cap Stocks Analysts Are Bullish On.
Hedge Fund Resource Center